Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Negative control outcome (NCO) analyses employed unadjusted p -values to prevent false negatives from excessive multiple comparison correction
Download the full survey infographic
The compound demonstrates notable stability in simulated gastric fluid conditions, making it a subject of interest in gastrointestinal research
In a Phase 2 trial that was published in the The New England Journal of Medicine participants achieved up to 24.2% average body weight loss at 48 week s while some higher dose groups gained 17.5% weight loss within just 24 weeks
US$ 28.94
US$ 25.82
US$ 20.52
US$ 25.00
US$ 24.37
